Growth Metrics

Resmed (RMD) Consolidated Net Income (2016 - 2025)

Resmed's Consolidated Net Income history spans 17 years, with the latest figure at $392.6 million for Q4 2025.

  • For Q4 2025, Consolidated Net Income rose 13.92% year-over-year to $392.6 million; the TTM value through Dec 2025 reached $1.5 billion, up 18.99%, while the annual FY2025 figure was $1.4 billion, 37.2% up from the prior year.
  • Consolidated Net Income reached $392.6 million in Q4 2025 per RMD's latest filing, up from $348.5 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $392.6 million in Q4 2025 to a low of -$78.5 million in Q1 2021.
  • Average Consolidated Net Income over 5 years is $247.8 million, with a median of $227.3 million recorded in 2022.
  • Peak YoY movement for Consolidated Net Income: tumbled 148.11% in 2021, then surged 328.1% in 2022.
  • A 5-year view of Consolidated Net Income shows it stood at $201.8 million in 2021, then increased by 11.48% to $224.9 million in 2022, then fell by 7.16% to $208.8 million in 2023, then surged by 65.05% to $344.6 million in 2024, then grew by 13.92% to $392.6 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Consolidated Net Income are $392.6 million (Q4 2025), $348.5 million (Q3 2025), and $379.7 million (Q2 2025).